Nuveen Asset Management LLC Has $2.07 Million Stock Holdings in Enhabit, Inc. (NYSE:EHAB)

Nuveen Asset Management LLC grew its position in shares of Enhabit, Inc. (NYSE:EHAB - Free Report) by 95.5% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 265,361 shares of the company's stock after buying an additional 129,610 shares during the quarter. Nuveen Asset Management LLC owned approximately 0.53% of Enhabit worth $2,072,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also made changes to their positions in the company. Paradice Investment Management LLC raised its stake in shares of Enhabit by 12.8% in the 4th quarter. Paradice Investment Management LLC now owns 1,780,113 shares of the company's stock valued at $13,903,000 after acquiring an additional 201,997 shares in the last quarter. Group One Trading LLC raised its position in shares of Enhabit by 248.3% in the fourth quarter. Group One Trading LLC now owns 7,746 shares of the company's stock valued at $60,000 after purchasing an additional 5,522 shares during the period. Corient Private Wealth LLC bought a new position in shares of Enhabit in the fourth quarter valued at approximately $79,000. Deutsche Bank AG lifted its stake in shares of Enhabit by 8.0% in the fourth quarter. Deutsche Bank AG now owns 242,999 shares of the company's stock worth $1,898,000 after buying an additional 17,941 shares during the last quarter. Finally, Price T Rowe Associates Inc. MD boosted its holdings in shares of Enhabit by 10.3% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 43,851 shares of the company's stock worth $343,000 after buying an additional 4,100 shares during the period.

Enhabit Stock Up 0.3%

EHAB traded up $0.04 during trading hours on Friday, hitting $10.80. 290,077 shares of the company's stock were exchanged, compared to its average volume of 457,464. The stock has a market cap of $546.63 million, a price-to-earnings ratio of -4.65 and a beta of 1.80. Enhabit, Inc. has a 1-year low of $6.85 and a 1-year high of $11.04. The stock's 50-day moving average is $9.01 and its two-hundred day moving average is $8.50. The company has a quick ratio of 1.46, a current ratio of 1.46 and a debt-to-equity ratio of 0.85.

Enhabit (NYSE:EHAB - Get Free Report) last posted its quarterly earnings results on Wednesday, May 7th. The company reported $0.10 EPS for the quarter, topping analysts' consensus estimates of $0.07 by $0.03. Enhabit had a positive return on equity of 1.67% and a negative net margin of 11.24%. The business had revenue of $259.90 million during the quarter, compared to analysts' expectations of $266.11 million. Sell-side analysts predict that Enhabit, Inc. will post 0.22 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Separately, Jefferies Financial Group restated a "buy" rating on shares of Enhabit in a research note on Thursday, March 6th.

Enhabit Profile

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.